| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |